Federal Register Notice: FDA has determined that Taxotere (docetaxel) injection, 40 mg/mL was
not withdrawn from sale for reasons of safety or effectiveness. This determination will allow the agency to approve ANDAs for docetaxel injection, 40 mg/mL, if all other legal and regulatory requirements are met. To view this notice, click here.
